DIN 02500833 — QINLOCK 50 MG
QINLOCK is a tablet of Ripretinib marketed by DECIPHERA PHARMACEUTICALS. LLC. The full Ripretinib monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02500833
- Brand name
- QINLOCK
- Active ingredient
- Ripretinib
- Strength
- 50 MG
- Dosage form
- TABLET
- Route
- ORAL
- Manufacturer
- DECIPHERA PHARMACEUTICALS. LLC
- Health Canada status
- MARKETED
- Drug class
- Tyrosine kinase inhibitor (KIT/PDGFRA inhibitor, antineoplastic agent)
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.